Quick Summary
Covering the latest research from top Wall Street investment banks

UBS raises its long-term uranium demand view as the energy security theme continues to support nuclear power and uranium stocks

Institution
UBS
Date
2026-04-10
Authors
Lachlan Shaw, Dim Ariyasinghe, George Eadie, Amy Yi Li, Fintan Collins, Levi Spry, Ben Wood, Al Harvey, Thomas Nightingale
Company
-
Ticker
-
Industry
Uranium / Global Basic Materials
Rating
NXG/NXE: Buy; CCO, PDN, BOE: Neutral
BullishLow confidenceThe report argues that energy security and energy diversification are increasing the appeal of the nuclear power theme, strengthening long-term demand momentum. However, near-term uranium spot prices will still be affected by macro market volatility and disruptions from diesel and sulfuric acid costs.
AuthorsLachlan Shaw, Dim Ariyasinghe, George Eadie, Amy Yi Li, Fintan Collins, Levi Spry, Ben Wood, Al Harvey, Thomas Nightingale
Target priceNXE: C$20/sh & A$21/sh; CCO: C$155/sh; PDN: A$12.60/sh; BOE: A$1.60/sh
CoverageUnited States、Other
Asset classesEquity、Commodity
Business segmentsUranium mining production、Uranium mine development、Nuclear power construction、Nuclear fuel supply chain
Research firm divisions/subsidiariesUBS(Other)

AI summary card

UBS raises its long-term uranium demand view as the energy security theme continues to support nuclear power and uranium stocks

UBS believes that nuclear power policy and procurement progress in the United States, China, India, Japan, and Taiwan are reinforcing long-term uranium demand, while near-term uranium prices, production costs, and supply-chain risks related to Middle East conflicts still need monitoring.

NXG/NXE remains at Buy, with target prices of C$20/sh and A$21/sh; CCO, PDN, and BOE remain at Neutral, with target prices of C$155/sh, A$12.60/sh, and A$1.60/sh, respectively.
UraniumNuclear powerEnergy securityEnergy diversificationUranium equitiesSupply-demand model
  • Long-term demand outlook raised by about 2%, mainly reflected beyond 2030.
  • The 2026e uranium price forecast was cut by 2% to US$88/lb, reflecting that spot prices are still influenced by market volatility.
  • The uranium spot price has fallen back to around US$85/lb, while the long-term price has risen to US$93/lb, up 16% year over year.
  • UBS prefers NXG/NXE, viewing its 12-18 month catalyst path and exposure to long-term uranium price upside as more attractive.
  • CCO, PDN, and BOE remain at Neutral, with the key differences centered on valuation, cost disruptions, project validation, and production execution.

Report interpretation

Overview

This report updates UBS's uranium supply-demand model. The core conclusion is that the strategic importance of nuclear power as a tool for energy security and energy diversification continues to rise, strengthening long-term demand momentum for uranium. Catalysts on the demand side include U.S. nuclear power revitalization policies, China's 2030 110GW nuclear power target, India's long-term uranium procurement, Japan's reactor restarts, and Taiwan's signals of nuclear power recalibration. At the same time, the report acknowledges that near-term uranium spot prices are not immune to macro market volatility, and therefore lowers the 2026e uranium price forecast to US$88/lb.

Core views

UBS remains incrementally positive on the nuclear power and uranium themes, especially against the backdrop of rising energy security pressures. Demand is more of a long-term story, becoming more evident after around 2030, while the supply side is relatively balanced: KAP's 2026 production is expected to rise by about 9%, but sulfuric acid, diesel, and logistical or cost disruptions stemming from Middle East conflicts remain key uncertainties. On individual stocks, UBS's top picks are NXG/NXE, followed by CCO, PDN, and BOE; however, aside from NXG/NXE being rated Buy, the other three companies are rated Neutral.

Analysis framework

The report combines an update to a top-down uranium supply-demand model with bottom-up company ratings: on the demand side, it assesses policy, nuclear installed capacity, long-term procurement, and reactor restarts; on the supply side, it tracks production guidance, project development, and the availability of consumables such as acid and diesel; on the valuation side, it uses NPV, DCF, EV/EBITDA, and P/E methods to evaluate companies with different uranium mining and nuclear power exposures.

Methodology notes

  • Supply-demand analysisUBS Uranium Supply-Demand Model

    Uranium supply-demand model

    It judges the medium- to long-term balance of the uranium market by considering nuclear installed capacity, reactor restarts, long-term procurement, mine production, and project commissioning pace.

  • Valuation methodsNPV / DCF / EV/EBITDA / P/E

    Multi-method valuation

    The report notes that target prices are generally based on a framework that gives 50% weight to NPV and 50% to EV/EBITDA; NXG/NXE use a sum-of-the-parts NPV approach, PDN and BOE use DCF assuming a 10% WACC and a long-term uranium price of US$100/lb, and CCO is based on P/E.

  • Rating frameworkForecast Stock Return

    12-month expected stock return

    UBS defines FSR as the sum of expected share price appreciation over the next 12 months plus dividend yield, and the equity target price investment horizon is 12 months.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Uranium
    Core commodity exposure
    Strengths
    Energy security, nuclear installed capacity, and long-term procurement demand provide structural support.
    Weaknesses
    The spot price is still subject to market risk appetite and liquidity disruptions.
    Comparison
    The long-term price trend is stronger than the recent spot price, showing that long-term contracts and supply-demand expectations remain firm.
    Risks
    Uranium price volatility, policy changes, and faster-than-expected supply recovery.
  • NXG/NXE
    Preferred uranium equity exposure
    Strengths
    It already has a construction permit, holds about C$1.1bn in cash, has catalysts over the next 12-18 months, and PCE drilling could provide unpriced upside.
    Weaknesses
    The project is still in the construction, financing, and execution phase, with elevated early shaft-sinking risk.
    Comparison
    Compared with other covered companies, UBS believes its exposure to uranium price upside and project catalysts is more attractive.
    Risks
    Project development delays, financing risk, construction execution risk, and future sales and pricing risk.
  • CCO
    High-quality diversified uranium and nuclear power exposure
    Strengths
    High business quality, diversified uranium/nuclear exposure, and long-duration procurement tied to AP1000 and Project Matador provide catalysts.
    Weaknesses
    Valuation is elevated and some catalysts are already reflected in the market.
    Comparison
    Quality and diversification are better than most peers, but valuation constraints keep the rating at Neutral.
    Risks
    North American demand timing falling short of expectations, policy headlines, and uranium price volatility.
  • PDN
    Uranium producer
    Strengths
    FY26 production guidance remains 4.0-4.4Mlb, Namibia is relatively supportive of mining, and the alkaline leach process reduces dependence on sulfuric acid.
    Weaknesses
    It is still exposed to diesel and acid cost disruptions, AUD movements, and short-term earnings volatility.
    Comparison
    Compared with ISR or acid-leach assets that rely on sulfuric acid, PDN is less dependent on sulfuric acid.
    Risks
    Namibia jurisdiction risk, mine safety, costs coming in above expectations, and production guidance changes.
  • BOE
    Australian uranium producer
    Strengths
    Most acid supply comes from its own or relatively controllable channels, and the impact of Middle East conflicts on consumables is not yet significant.
    Weaknesses
    Weather has reduced production expectations, and the new feasibility study still needs to validate the wide-spaced well design.
    Comparison
    Compared with PDN, BOE needs the Q3 CY26 feasibility study to rebuild market confidence in its expansion plan.
    Risks
    Regulatory risk, mine safety, production falling short of expectations, and failure to validate the expansion plan.
  • KAP
    Key global uranium supplier
    Strengths
    2026 production is expected to grow by about 9%, with the Budenovskoye JV ramp-up providing incremental output.
    Weaknesses
    Historically has had exposure to sulfuric acid availability.
    Comparison
    Its supply growth is more balanced for the market, but the impact from Middle East conflicts and acid supply still needs to be monitored.
    Risks
    Sulfuric acid supply, diesel availability, geopolitics, and operational disruptions.

Key data

  • Long-term uranium demand outlook+about 2%The upgrade is mainly reflected from around 2030e onward.
  • 2026e uranium price forecastUS$88/lbCut by 2% versus the prior forecast.
  • Uranium spot priceabout US$85/lbIt has retreated after previously stalling near US$100/lb.
  • Long-term uranium priceUS$93/lbUp 16% year over year.
  • Production cost indicatorabout US$60/lbFrom Tradetech's recent production cost indicator.
  • Physical trust buyingabout 6Mlb YTDUBS estimate of physical trust purchases year to date.
  • U.S. DOE UPRISE target+2.5GW in 2027, +5GW in 2029Short-term capacity expansion through higher output from existing reactors, restarts of shut-down projects, and completion of shelved projects.
  • China nuclear power target110GW by 2030The draft 15th Five-Year Plan continues to confirm an expansion target of about 10GW per year.
  • CCO and India long-term agreementabout 22Mlb, 9 yearsUsed to support India's target of 100GW of nuclear power by 2047.
  • KAP 2026 production guidance+about 9%Mainly from the ramp-up of the Budenovskoye JV.
  • NXE target priceC$20/sh & A$21/shRated Buy and UBS's preferred uranium exposure.
  • CCO target priceC$155/shRated Neutral.
  • PDN target priceA$12.60/shRated Neutral.
  • BOE target priceA$1.60/shRated Neutral.

Impact & implications

The investment implication of the report is that the medium- to long-term fundamentals for uranium and the nuclear power theme continue to receive policy and energy security support, but near-term trading should not ignore macro volatility, project execution, cost inflation, and supply-chain disruptions. Better risk-adjusted returns may come from project companies with clear permitting, financing, and development catalysts, while mature producers or diversified nuclear power exposure companies, although of higher quality, may face limited near-term upside due to valuation and expectations already being priced in.

Risks

  • Uranium spot prices may continue to be affected by macro market volatility and declining risk appetite.
  • Middle East conflicts may affect diesel, sulfuric acid, and logistics availability, thereby impacting uranium mining costs or production.
  • Nuclear power policies, approvals, and reactor construction timelines may proceed more slowly than the market expects.
  • Uranium mining projects face financing, construction, permitting, and execution risks.
  • Mining companies are exposed to commodity price, foreign exchange, political, financial, operational, and mine safety risks.
  • Uranium mining also carries nuclear energy policy attributes and risks related to radioactive ores.
  • Valuations for some mature nuclear power and uranium exposure companies may already reflect the medium- to long-term positives.

What to watch

  • The U.S. DOE UPRISE plan, NRC approval process reforms, and progress on TerraPower Natrium.
  • China's 15th Five-Year Plan nuclear installed capacity target and the pace of actual additions.
  • India's long-term uranium procurement and execution of its 2047 100GW nuclear power target.
  • The restart progress of Kashiwazaki-Kariwa 6 in Japan.
  • Taiwan's Maanshan restart application and signals of nuclear power policy recalibration.
  • The supply-chain status of assets with relatively high dependence on sulfuric acid and diesel, such as KAP, Rossing, and Husab.
  • NXG/NXE's construction readiness, shaft sinking, PCE drilling, and utility customer relationship progress.
  • PDN's MQ26 production, FY26 guidance, PLS project updates, and cost performance.
  • BOE's Q3 CY26 new feasibility study and validation of the wide-spaced well design.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins